According to Roche's latest financial reports the company's current EPS (TTM) is โน1,444. In 2022 the company made an earnings per share (EPS) of โน1,444 a decrease over its 2021 EPS that were of โน1,541.
Year | EPS | Change |
---|---|---|
2022 | โน1,444 | -6.29% |
2021 | โน1,541 | -5.53% |
2020 | โน1,631 | 16.56% |
2019 | โน1,399 | 30.3% |
2018 | โน1,074 | 20.22% |
2017 | โน893.18 | -5.81% |
2016 | โน948.24 | 4.62% |
2015 | โน906.37 | -5.13% |
2014 | โน955.43 | -25.05% |
2013 | โน1,275 | 21.73% |
2012 | โน1,047 | 3.82% |
2011 | โน1,009 | 8.16% |
2010 | โน932.51 | 23.72% |
2009 | โน753.70 | -12.31% |
2008 | โน859.48 | -0.34% |
2007 | โน862.44 | 32.13% |
2006 | โน652.71 | 42.56% |
2005 | โน457.85 | -22.7% |
2004 | โน592.27 | 132.85% |
2003 | โน254.36 | -154.73% |
2002 | -โน464.74 | -209.09% |
2001 | โน426.01 | -57.25% |
2000 | โน996.41 | 54.06% |
1999 | โน646.76 | 31.24% |
1998 | โน492.82 |